Jari Petäjä
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jari Petäjä has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Markku Heikinheimo
University of Helsinki
4 shared publications - Satu Långström
Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
3 shared publications Ulla Wartiovaara-Kautto
3 shared publicationsKaija Peltola
2 shared publicationsLeena Mildh
2 shared publicationsM. Syrjälä
Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland
2 shared publications
Latest Publications
- 1 January 2011
- Published by Elsevier in Thrombosis Research
- Vol. 127, S34-S37
Inflammation and coagulation. An overview
- 1 January 2011
- Published by Elsevier in Thrombosis Research
- Vol. 127, S34-S37
Inflammation and coagulation. An overview
- 1 December 2008
- Vol. 100 (6) , 1207-8
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery.
- 1 December 2008
- Vol. 100 (6) , 1207-8
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery.
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 100 (12) , 1207-1208
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery
- 1 January 2008
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 100 (12) , 1207-1208
Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery
- 1 August 2006
- Vol. 96 (2) , 142-8
Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Exchange transfusion (ET) with adult blood is a standard procedure for neonates with severe hyperbilirubinemia. How ET affects newborn coagulation system remains, however, largely unknown. Thus, we prospectively evaluated the effect of ET on thrombin formation and coagulation profile in 18 newborns (22 ETs). Prothrombin fragment F1+2 and thrombin-antithrombin complexes increased considerably during ET while platelets were significantly reduced. Protein C increased less (p < 0.001) and factor VIIIc more (p < 0.001) than expected based on their levels in the infused blood. Further, in vitro thrombin generation initiated by 5 pM tissue factor was analysed. Before the first ET, newborn endogenous thrombin potential (ETP) and thrombin peak remained at approximately 60% of adult control plasma levels, but the lag time to thrombin burst in newborn plasma was approximately 45% shorter than the lag time in adult plasma. At the end of the first ET, the thrombin burst still started approximately 35% earlier in newborn than adult plasma, whereas ETP and thrombin peak were increased to > 90% of adult levels. ETP and peak remained elevated at adult levels until the beginning of the second ET. APC-induced reductions in newborn ETP remained unaltered throughout the first ET. The reductions of ETP by APC were less pronounced in newborn than adult plasma (p < 0.0001). We conclude that ET is associated with multiple procoagulant changes and increased in vivo thrombin formation. This ET-induced procoagulant challenge may be of clinical significance in sick newborns already prone to bleeding and thrombotic complications.
- 1 August 2006
- Vol. 96 (2) , 142-8
Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Exchange transfusion (ET) with adult blood is a standard procedure for neonates with severe hyperbilirubinemia. How ET affects newborn coagulation system remains, however, largely unknown. Thus, we prospectively evaluated the effect of ET on thrombin formation and coagulation profile in 18 newborns (22 ETs). Prothrombin fragment F1+2 and thrombin-antithrombin complexes increased considerably during ET while platelets were significantly reduced. Protein C increased less (p < 0.001) and factor VIIIc more (p < 0.001) than expected based on their levels in the infused blood. Further, in vitro thrombin generation initiated by 5 pM tissue factor was analysed. Before the first ET, newborn endogenous thrombin potential (ETP) and thrombin peak remained at approximately 60% of adult control plasma levels, but the lag time to thrombin burst in newborn plasma was approximately 45% shorter than the lag time in adult plasma. At the end of the first ET, the thrombin burst still started approximately 35% earlier in newborn than adult plasma, whereas ETP and thrombin peak were increased to > 90% of adult levels. ETP and peak remained elevated at adult levels until the beginning of the second ET. APC-induced reductions in newborn ETP remained unaltered throughout the first ET. The reductions of ETP by APC were less pronounced in newborn than adult plasma (p < 0.0001). We conclude that ET is associated with multiple procoagulant changes and increased in vivo thrombin formation. This ET-induced procoagulant challenge may be of clinical significance in sick newborns already prone to bleeding and thrombotic complications.
- Open Access
- 13 January 2006
- Published by Springer Nature in Critical Care
- Vol. 10 (1) , R16
Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis
Introduction: Disturbed protein C (PC) pathway homeostasis might contribute to the development of multiple organ failure (MOF) in acute pancreatitis (AP). We therefore evaluated circulating levels of PC and activated protein C (APC), evaluated monocyte deactivation in AP patients, and determined the relationship of these parameters to MOF. Patients and methods: Thirty-one patients in the intensive care unit were categorized as cases (n = 13, severe AP with MOF) or controls (n = 18, severe AP without MOF). Blood samples were drawn every second day to determine the platelet count, the levels of APC, PC, and D-dimer, and the monocyte HLA-DR expression using flow cytometry. The APC/PC ratio was used to evaluate turnover of PC to APC. Results: During the initial two weeks of hospitalization, low PC levels (P = 0.008). The minimum APC level was lower in cases than in controls (median 85% versus 97%, P = 0.009). Using 87% as the cut-off value, 8/13 (62%) cases and 3/18 (17%) controls showed reduced APC levels (P = 0.021). A total of 92% of cases and 50% of controls had APC/PC ratios exceeding the upper normal limit (P = 0.013). Plasma samples drawn before MOF showed low PC levels and high APC/PC ratios. HLA-DR-positive monocytes correlated with PC levels (r = 0.38, P < 0.001) and APC levels (r = 0.27, P < 0.001), indicating that the PC pathway was associated with systemic inflammation-triggered immune suppression. Conclusion: PC deficiency and decreased APC generation in severe AP probably contributed to a compromised anticoagulant and anti-inflammatory defence. The PC pathway defects were associated with the development of MOF. The data support feasibility of testing the use of APC or PC to improve the clinical outcome in AP.
- 13 January 2006
- Published by Springer Nature in Critical Care
- Vol. 10 (1) , R16
Open AccessUpregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis
Introduction: Disturbed protein C (PC) pathway homeostasis might contribute to the development of multiple organ failure (MOF) in acute pancreatitis (AP). We therefore evaluated circulating levels of PC and activated protein C (APC), evaluated monocyte deactivation in AP patients, and determined the relationship of these parameters to MOF. Patients and methods: Thirty-one patients in the intensive care unit were categorized as cases (n = 13, severe AP with MOF) or controls (n = 18, severe AP without MOF). Blood samples were drawn every second day to determine the platelet count, the levels of APC, PC, and D-dimer, and the monocyte HLA-DR expression using flow cytometry. The APC/PC ratio was used to evaluate turnover of PC to APC. Results: During the initial two weeks of hospitalization, low PC levels (P = 0.008). The minimum APC level was lower in cases than in controls (median 85% versus 97%, P = 0.009). Using 87% as the cut-off value, 8/13 (62%) cases and 3/18 (17%) controls showed reduced APC levels (P = 0.021). A total of 92% of cases and 50% of controls had APC/PC ratios exceeding the upper normal limit (P = 0.013). Plasma samples drawn before MOF showed low PC levels and high APC/PC ratios. HLA-DR-positive monocytes correlated with PC levels (r = 0.38, P < 0.001) and APC levels (r = 0.27, P < 0.001), indicating that the PC pathway was associated with systemic inflammation-triggered immune suppression. Conclusion: PC deficiency and decreased APC generation in severe AP probably contributed to a compromised anticoagulant and anti-inflammatory defence. The PC pathway defects were associated with the development of MOF. The data support feasibility of testing the use of APC or PC to improve the clinical outcome in AP.
- 30 July 2004
- Published by Wiley in Transfusion Medicine
- Vol. 14 (4) , 281-288
A simple automatized audit system for following and managing practices of platelet and plasma transfusions in a neonatal intensive care unit
Summary. During neonatal intensive care, blood components are often used in clinical situations where both their efficacy and safety lack solid justification. A practical system to continuously analyse actual transfusion practices is a prerequisite for improvements of quality in transfusion therapy. We hypothesized that such a system would reveal inappropriate variations in clinical decission making and offer a means for staff education and quality improvement and assurance.The study consisted of three 120–152‐day periods (P I, P II and P III) between January 2000 and October 2001 and involved 543 new patient admissions (141 patients with birth weight < 1501 g) and 6227 days of patient care at a single tertiary level NICU. P I was a control with no intervention, P II was after technically introducing the computer system and, the last period, P III was after presenting and discussing the results of P I and P II at a staff meeting. Upon an order of platelet or fresh frozen plasma (FFP) unit from the blood bank, a computer‐based audit system compared the last platelet count or prothrombin time [expressed as percentage of normal clotting activity, prothrombin time (PT‐%)] to predefined criteria. In the case of exceeding the preset thresholds, the system required additional information and recorded the pretransfusion laboratory values for later analysis.Thirty‐two per cent of platelet transfusions were given with pretransfusion platelet count >49 × 109 L−1, and 60% of these transfusions (19% of all platelet transfusions) could not be clinically justified in retrospective chart review. There was no significant change in this practice from P II to P III. FFP transfusions were given with significantly different pretransfusion PT‐% values during P II and P III. The proportions of FFP transfusions with pretransfusion PT‐% > 49% were 7·8% and 0·9% during P II and P III, respectively (P < 0·0001). In chart review, none of the FFP transfusions with pretransfusion PT‐% > 49% could be justified by clinical grounds.Inappropriate transfusions of both platelets and plasma remain a significant challenge for quality assurance of neonatal intensive care. Automated recording of pretransfusion platelet count and prothrombin time reliably identified the poorly justified transfusions and thus offered a practical resource‐saving tool for quality assurance of transfusion in the NICU. A significant shift towards more appropriate use of plasma was demonstrated after implementation of the audit system.
- 30 July 2004
- Published by Wiley in Transfusion Medicine
- Vol. 14 (4) , 281-288
A simple automatized audit system for following and managing practices of platelet and plasma transfusions in a neonatal intensive care unit
Summary. During neonatal intensive care, blood components are often used in clinical situations where both their efficacy and safety lack solid justification. A practical system to continuously analyse actual transfusion practices is a prerequisite for improvements of quality in transfusion therapy. We hypothesized that such a system would reveal inappropriate variations in clinical decission making and offer a means for staff education and quality improvement and assurance.The study consisted of three 120–152‐day periods (P I, P II and P III) between January 2000 and October 2001 and involved 543 new patient admissions (141 patients with birth weight < 1501 g) and 6227 days of patient care at a single tertiary level NICU. P I was a control with no intervention, P II was after technically introducing the computer system and, the last period, P III was after presenting and discussing the results of P I and P II at a staff meeting. Upon an order of platelet or fresh frozen plasma (FFP) unit from the blood bank, a computer‐based audit system compared the last platelet count or prothrombin time [expressed as percentage of normal clotting activity, prothrombin time (PT‐%)] to predefined criteria. In the case of exceeding the preset thresholds, the system required additional information and recorded the pretransfusion laboratory values for later analysis.Thirty‐two per cent of platelet transfusions were given with pretransfusion platelet count >49 × 109 L−1, and 60% of these transfusions (19% of all platelet transfusions) could not be clinically justified in retrospective chart review. There was no significant change in this practice from P II to P III. FFP transfusions were given with significantly different pretransfusion PT‐% values during P II and P III. The proportions of FFP transfusions with pretransfusion PT‐% > 49% were 7·8% and 0·9% during P II and P III, respectively (P < 0·0001). In chart review, none of the FFP transfusions with pretransfusion PT‐% > 49% could be justified by clinical grounds.Inappropriate transfusions of both platelets and plasma remain a significant challenge for quality assurance of neonatal intensive care. Automated recording of pretransfusion platelet count and prothrombin time reliably identified the poorly justified transfusions and thus offered a practical resource‐saving tool for quality assurance of transfusion in the NICU. A significant shift towards more appropriate use of plasma was demonstrated after implementation of the audit system.
- 30 September 2003
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 29 (4) , 349-362
Protein C Pathway in Infants and Children
The protein C pathway comprises a major physiological anticoagulant system. Its major congenital defects, heterozygous deficiencies of protein C and protein S as well as activated protein C resistance due to G1691A mutated factor V (Factor V Leiden), are associated with pediatric venous thromboembolic disease. The protein C pathway is centrally involved in the control of both coagulation and inflammation during sepsis and other inflammatory conditions presenting with disseminated intravascular coagulation. This article reviews the physiology of the protein C pathway with special emphasis on pediatric aspects. Clinical implications of the protein C pathway defects in pediatric venous thromboembolism as well as acquired disturbances of protein C pathway during sepsis are discussed.
- 30 September 2003
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 29 (4) , 349-362
Protein C Pathway in Infants and Children
The protein C pathway comprises a major physiological anticoagulant system. Its major congenital defects, heterozygous deficiencies of protein C and protein S as well as activated protein C resistance due to G1691A mutated factor V (Factor V Leiden), are associated with pediatric venous thromboembolic disease. The protein C pathway is centrally involved in the control of both coagulation and inflammation during sepsis and other inflammatory conditions presenting with disseminated intravascular coagulation. This article reviews the physiology of the protein C pathway with special emphasis on pediatric aspects. Clinical implications of the protein C pathway defects in pediatric venous thromboembolism as well as acquired disturbances of protein C pathway during sepsis are discussed.
- 1 June 2003
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (6) , 1189-1194
Fresh frozen plasma reduces thrombin formation in newborn infants
- 1 June 2003
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (6) , 1189-1194
Fresh frozen plasma reduces thrombin formation in newborn infants
- 1 January 2002
- Vol. 118 (12) , 1217-9
[Protein C--a new opening in the treatment of sepsis syndrome].
- 1 January 2002
- Vol. 118 (12) , 1217-9
[Protein C--a new opening in the treatment of sepsis syndrome].